NEWS: Damage to a #Baxter facility caused by #HurricaneHelene has led to #shortages in some critical medicines, says FDA. https://lnkd.in/eGb_-uUk
pharmaphorum
Media Production
London, England 10,507 followers
Industry leading publications, strategic consulting and a content-driven stakeholder engagement agency
About us
pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate. www.pharmaphorum.com
- Website
-
https://pharmaphorum.com/about/
External link for pharmaphorum
- Industry
- Media Production
- Company size
- 11-50 employees
- Headquarters
- London, England
- Type
- Privately Held
- Founded
- 2009
- Specialties
- pharmaceuticals, media, biotech, networking, marketing, sales, R&D, devices, diagnostics, commercial, content, communications, creative, consulting, publishing, market access, patients, digital health, and oncology
Locations
-
Primary
6 Kean Street
5th Floor
London, England WC2B 4AS, GB
Employees at pharmaphorum
Updates
-
The FT Live Global Pharma & Biotech Summit will host over 250 leading executives from the life sciences, pharmaceutical and biotechnology industries to discuss new areas such as drug discovery, clinical trials, market access and patient engagement. Download the brochure now to see the confirmed CEO speakers, key topics and who you can meet: https://bit.ly/3XuwDc4 Save 20% on your in-person or digital pass with discount code PHARMAPHORUM: https://bit.ly/3XuwDc4 #FTPharma
-
NEWS: Faced with lawsuit, FDA rethinks block on compounding pharmacies making #EliLillyandCo's #diabetes and #obesity drug tirzepatide. https://lnkd.in/e7PZfY3X
FDA rethinking block on compounding of Lilly's obesity drug
pharmaphorum.com
-
NEWS: #Pfizer's Hympavzi is the first anti-TFPI antibody to be cleared by FDA to treat #haemophilia. https://lnkd.in/eMQXw5JR
Pfizer rounds out haemophilia portfolio with FDA approval
pharmaphorum.com
-
NEWS: #Sanofi confirms discussions with private equity firm CD&R over the sale of a controlling stake in its #consumerhealth business Opella. https://lnkd.in/eQr7w6gB
Sanofi in talks to sell stake in consumer health spinout
pharmaphorum.com
-
NEWS: FDA gives #Roche the first approval for PI3K inhibitor Itovebi, clearing the drug for certain types of advanced #breastcancer. #oncology https://lnkd.in/eqN_6gyS
Roche gets FDA green light for breast cancer drug Itovebi
pharmaphorum.com
-
NEWS: US Senator asks #FTC to scrutinise $16.5bn Novo Holdings/Catalent merger and sale of #pharma manufacturing plants to #NovoNordisk. https://lnkd.in/egi6FZUn
Lawmaker asks FTC to probe Novo/Catalent deal
pharmaphorum.com
-
NEWS: Activist investor #StarboardValue claims former #Pfizer execs Ian Read and Frank D'Amelio were bullied into lending their support to current management. https://lnkd.in/eafWri-x
Starboard claims Pfizer 'threatened' former leaders
pharmaphorum.com
-
NEWS: #EVERSANA teams up with #OracleArgusCloud to add to the features of its #pharmacovigilance platform. https://lnkd.in/eU3N9fxD
EVERSANA partners Oracle on pharmacovigilance platform
pharmaphorum.com
-
Identifying high-volume prescribers and engaging with KOLs in a target therapeutic area can be a challenge. Join PurpleLab experts Theodore Sweetser, VP of Advertising Partnerships and Strategy, Matthew Ryklin, Director of Solution Engineering, and Amy Crowe, VP of Go-To-Market Enablement in our upcoming webinar, as they explore how PurpleLab's Masterfiles can help foster a deeper understanding of physician #prescribingbehaviour. https://lnkd.in/gH7MfgEC